Figure S2 from Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer

Key Points

• mTOR inhibition initiates ferritinophagy and ferroptosis in head and neck cancer cells, highlighting potential treatment targets.
• Key evidence indicates that inhibiting mTOR leads to significant changes in cellular processes related to cancer progression.
• Observational analysis reveals mTOR inhibitors trigger autophagy in HNSCC cells, suggesting a mechanism for cancer cell death.
• These findings may enable new therapeutic approaches in treating head and neck cancer, pointing to the significance of mTOR pathways.